Skip to main content
. 2021 Aug 16;9(8):910. doi: 10.3390/vaccines9080910
Ab antibody
ACE2 angiotensin-converting enzyme 2
ARDS acute respiratory distress syndrome
CLIA chemiluminescent immunoassay
CMIA chemiluminescent microparticle immunoassay
COVID-19 coronavirus disease 2019
E envelope
ECLIA electro-chemiluminescence immunoassay
ELFA enzyme-linked fluorescent assay
ELISA enzyme-linked immunosorbent assay
HCoVs human coronaviruses
IgA immunoglobulin A
IgG immunoglobulin G
IgM immunoglobulin M
M membrane
MERS Middle East respiratory syndrome
N nucleocapsid
NAbs neutralizing antibodies
PRNT plaque reduction neutralization tests
RBD receptor-binding domain
S spike
SARS-CoV-2 severe acute respiratory syndrome coronavirus 2
SARS severe acute respiratory syndrome
TMPRSS2 transmembrane protease serine 2
WHO World Health Organization